The reason the body stops producing insulin is that it kills off the pancreas’ beta cells, which produce insulin. People with Type 1 diabetes must get their insulin from injections or ingestion, a cumbersome and often imprecise task. Too little insulin and blood sugar levels stay high for extended periods, potentially damaging the body; too much and blood sugar levels crash, possibly causing a person with diabetes to faint or experience an even worse problems, such as a stroke.
Gupta says that with her patients, “we typically emphasize cutting out processed food and sugary drinks to begin with, and exercise recommendations include 150 minutes of moderate-intensity cardiovascular exercise per week, and two to three days per week of strength training, which is consistent with exercise guidelines from the Centers for Disease Control and Prevention.” The American Diabetes Association recommends replacing high-fat, high-sugar, high-salt foods with a mix of fiber, protein, fruits, and vegetables to keep blood sugar levels steady.
For 15 years, Erez Benari’s struggle with his type 2 diabetes had been a losing one. A software engineer at Microsoft in Seattle, Washington, Benari had stuck to a restrictive diet that kept him off most carbs, along with regular insulin shots. But still, his high blood sugar levels never dropped, while his health continued to decline. In 2013, the then 39-year-old Benari suffered a heart attack.
Dr. May currently works as a fulltime endocrinologist and has been in private practice since 2004. He has a variety of interests, predominantly obesity and diabetes, but also sees patients with osteoporosis, thyroid disorders, men's health disorders, pituitary and adrenal disorders, polycystic ovaries, and disorders of growth. He is a leading member of several obesity and diabetes societies and runs a trial centre for new drugs.
There are major barriers for widespread use of islet also-transplantation that can help people with type 1 diabetes. The shortage of islets from donors is a huge obstacle. The other obstacle is that this is still considered an experimental procedure and until the procedure is considered successful enough to be labeled therapeutic by the FDA instead of experimental, the costs of these transplants come from limited research funds.
It’s a clinical trial that is being held at mass general. I am surprised by the rather negative comments on here. I am happily going to the Faustma Lab in a few weeks to meet with Denise and see what the study is about. You should contact Mass General and find out more. I am a Boston area native but flying 1500miles to learn about the study. Typically insurance companies don’t conduct or have much to do with clinical trials. They can’t make money off us if we are cured or using less insulin! Oh insurance companies are such pains… Read more »
I just wanted to drop you a line and thank you for that post… My lab results at the beginning of the month were 230. After just this last week it’s down to 155. I think I’ll be in normal range within a month. Really miraculous… It’s really been a game changer for me already and I wanted you to know how much I appreciated the info and how much of a difference I think it will make in my life.